论文部分内容阅读
目的:观察稳心颗粒联合胺碘酮治疗室性期前收缩的临床疗效。方法:选取120例室性期前收缩患者作为研究对象,随机分为2组各60例。观察组口服稳心颗粒联合盐酸胺碘酮胶囊治疗,对照组单用盐酸胺碘酮胶囊治疗,2组均治疗8周。比较2组的治疗效果。结果:临床疗效总有效率观察组为95.00%,对照组为75.00%,2组比较,差异有统计学意义(P<0.01)。治疗后,2组24 h动态心电图室性期前收缩次数均较治疗前下降(P<0.01),观察组收缩次数少于对照组(P<0.01)。观察组不良反应发生率低于对照组(P<0.01)。结论:稳心颗粒联合胺碘酮可有效提高临床治疗效果、减少室性期前收缩发生次数,且不良反应少。
Objective: To observe the clinical effect of Wenxin granule combined with amiodarone in the treatment of premature ventricular contractions. Methods: 120 cases of premature ventricular contractions were selected as study subjects and randomly divided into two groups of 60 cases. The observation group was given oral Wenxin granule combined with amiodarone hydrochloride capsule, while the control group was treated with amiodarone hydrochloride alone. The two groups were treated for 8 weeks. Compare the treatment effect of 2 groups. Results: The total effective rate of clinical efficacy was 95.00% in the observation group and 75.00% in the control group. There was significant difference between the two groups (P <0.01). After treatment, the number of premature ventricular contractions 24 hours after operation in both groups were significantly lower than those before treatment (P <0.01). The number of contractions in the observation group was less than that in the control group (P <0.01). The incidence of adverse reactions in the observation group was lower than that in the control group (P <0.01). Conclusion: Wenshen granules combined with amiodarone can effectively improve the clinical therapeutic effect, reduce the incidence of ventricular premature contractions, and less adverse reactions.